Aziz Benzohra

1.4k total citations
4 papers, 378 citations indexed

About

Aziz Benzohra is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Aziz Benzohra has authored 4 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 2 papers in Pathology and Forensic Medicine and 2 papers in Hematology. Recurrent topics in Aziz Benzohra's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (2 papers). Aziz Benzohra is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (2 papers). Aziz Benzohra collaborates with scholars based in United Kingdom, Taiwan and Poland. Aziz Benzohra's co-authors include David Cunningham, Răzvan Popescu, Peter Johnson, James M. Foran, A. Z. S. Rohatiner, Christian Gisselbrecht, Bertrand Souleau, Félix Reyes, Michele Ghielmini and E.M. Bessell and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Clinical Lymphoma Myeloma & Leukemia.

In The Last Decade

Aziz Benzohra

4 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aziz Benzohra United Kingdom	3	296	214	178	83	66	4	378
Pär Josefsson Denmark	10	252 0.9×	179 0.8×	124 0.7×	38 0.5×	109 1.7×	18	369
Federica Quirini Italy	11	372 1.3×	116 0.5×	179 1.0×	50 0.6×	115 1.7×	17	432
Annalisa Gabriele Italy	8	255 0.9×	88 0.4×	112 0.6×	37 0.4×	39 0.6×	12	315
Carola Boccomini Italy	8	390 1.3×	106 0.5×	224 1.3×	76 0.9×	43 0.7×	21	435
Rosa Ruchlemer United Kingdom	6	240 0.8×	135 0.6×	85 0.5×	35 0.4×	48 0.7×	8	291
Ulrich von Gruenhagen Germany	10	421 1.4×	289 1.4×	266 1.5×	14 0.2×	45 0.7×	11	458
Maya Hacini France	6	285 1.0×	114 0.5×	189 1.1×	21 0.3×	33 0.5×	15	358
Sotirios Sachanas Greece	12	209 0.7×	158 0.7×	146 0.8×	33 0.4×	43 0.7×	34	384
Taoufik El Gnaoui France	7	341 1.2×	120 0.6×	226 1.3×	48 0.6×	40 0.6×	17	388
Joanna Gambell United Kingdom	6	436 1.5×	157 0.7×	289 1.6×	42 0.5×	24 0.4×	8	492

Countries citing papers authored by Aziz Benzohra

Since Specialization

Citations

This map shows the geographic impact of Aziz Benzohra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aziz Benzohra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aziz Benzohra more than expected).

Fields of papers citing papers by Aziz Benzohra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aziz Benzohra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aziz Benzohra. The network helps show where Aziz Benzohra may publish in the future.

Co-authorship network of co-authors of Aziz Benzohra

This figure shows the co-authorship network connecting the top 25 collaborators of Aziz Benzohra. A scholar is included among the top collaborators of Aziz Benzohra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aziz Benzohra. Aziz Benzohra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

Erba, Harry P., Pau Montesinos, Radovan Vrḫovac, et al.. (2022). Poster: AML-029 Quizartinib Prolonged Overall Survival (OS) vs Placebo Plus Intensive Induction and Consolidation Therapy Followed by Single-Agent Continuation in Patients Aged 18-75 Years With Newly Diagnosed FLT3–Internal Tandem Duplication Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML). Clinical Lymphoma Myeloma & Leukemia. 22. S124–S124. 1 indexed citations

Erba, Harry P., Pau Montesinos, Radovan Vrḫovac, et al.. (2022). AML-029 Quizartinib Prolonged Overall Survival (OS) vs Placebo Plus Intensive Induction and Consolidation Therapy Followed by Single-Agent Continuation in Patients Aged 18-75 Years With Newly Diagnosed FLT3–Internal Tandem Duplication Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML). Clinical Lymphoma Myeloma & Leukemia. 22. S208–S209. 6 indexed citations

Foran, James M., A. Z. S. Rohatiner, David Cunningham, et al.. (2000). European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma. Journal of Clinical Oncology. 18(2). 317–317. 368 indexed citations

Cunningham, David, Răzvan Popescu, F. Cavalli, et al.. (1998). Immunotherapy of mantle cell lymphoma (MCL), lymphoplasmacytoid lymphoma (LPC) and Waldenstrom's macroglobulinemia (WM), and small lymphocytic lymphoma (SLL) with rituximab (IDEC-C288): Preliminary results of an ongoing international multicentre trial. British Journal of Haematology. 102. 149–149. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact